Skip to main content
. 2022 Aug 16;29(1):2685–2693. doi: 10.1080/10717544.2022.2111479

Figure 8.

Figure 8.

In vivo pharmacokinetic profile of raloxifene plasma levels following treatment with either EVISTA (black) or Ral/HSA/PSS NPs (red) in a female Wistar rat model. All data points are represented as mean ± SD (n = 5).